BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11888747)

  • 1. Management of infected femoral closure devices.
    Geary K; Landers JT; Fiore W; Riggs P
    Cardiovasc Surg; 2002 Apr; 10(2):161-3. PubMed ID: 11888747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Femoral artery infections associated with percutaneous arterial closure devices.
    Johanning JM; Franklin DP; Elmore JR; Han DC
    J Vasc Surg; 2001 Dec; 34(6):983-5. PubMed ID: 11743549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Groin infection caused by a percutaneous femoral artery closure device: report of a case.
    Yamamoto N; Koyano K; Azuma M; Ochiai H; Kashiwabara T
    Surg Today; 2003; 33(10):801-4. PubMed ID: 14513335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudication secondary to Perclose use after percutaneous procedures.
    Jang JJ; Kim M; Gray B; Bacharach JM; Olin JW
    Catheter Cardiovasc Interv; 2006 May; 67(5):687-95. PubMed ID: 16586517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious complications related to the use of the angio-seal hemostatic puncture closure device.
    Cooper CL; Miller A
    Catheter Cardiovasc Interv; 1999 Nov; 48(3):301-3. PubMed ID: 10525234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous arterial closure in peripheral vascular disease: a prospective randomized evaluation of the Perclose device.
    Starnes BW; O'Donnell SD; Gillespie DL; Goff JM; Rosa P; Parker MV; Chang A
    J Vasc Surg; 2003 Aug; 38(2):263-71. PubMed ID: 12891107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Femoral artery infection associated with a percutaneous arterial suture device.
    Tiesenhausen K; Tomka M; Allmayer T; Baumann A; Hessinger M; Portugaller H; Mahler E
    Vasa; 2004 May; 33(2):83-5. PubMed ID: 15224460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified "preclosure" technique after percutaneous aortic valve replacement.
    Kahlert P; Eggebrecht H; Erbel R; Sack S
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):877-84. PubMed ID: 19006257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial.
    Martin JL; Pratsos A; Magargee E; Mayhew K; Pensyl C; Nunn M; Day F; Shapiro T
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):1-5. PubMed ID: 18098171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the Perclose suture-mediated closure system be used safely in patients undergoing diagnostic and therapeutic angiography to treat chronic lower extremity ischemia?
    Mackrell PJ; Kalbaugh CA; Langan EM; Taylor SM; Sullivan TM; Gray BH; Carsten CG; Snyder BA; Cull DL; Youkey JR
    J Vasc Surg; 2003 Dec; 38(6):1305-8. PubMed ID: 14681632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous femoral closure following stent-graft placement: use of the Perclose device.
    Quinn SF; Kim J
    Cardiovasc Intervent Radiol; 2004; 27(3):231-6. PubMed ID: 15037951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early experience with infectious complications of percutaneous femoral artery closure devices.
    Pipkin W; Brophy C; Nesbit R; Mondy Iii JS
    J Vasc Surg; 2000 Jul; 32(1):205-8. PubMed ID: 10876226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular complications at the femoral access: impact of the percutaneous closure device Perclose].
    Mboup MC; Moquet B; Zabalawi A; Delaunay R
    Ann Cardiol Angeiol (Paris); 2014 Apr; 63(2):71-4. PubMed ID: 24613004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of total percutaneous closure of femoral arterial access sites after veno-arterial extracorporeal membrane oxygenation.
    Xu X; Liu Z; Han P; He M; Xu Y; Yin L; Xu Z; Liang Q; Huang M
    Medicine (Baltimore); 2019 Nov; 98(45):e17910. PubMed ID: 31702668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of a percutaneous suture-mediated closure system after 6 - 8F transfemoral approaches: results for 2200 patients].
    Kamusella P; Wissgott C; Andresen R
    Rofo; 2012 Apr; 184(4):311-5. PubMed ID: 22274872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Totally percutaneous aortic aneurysm repair: experience and prudence.
    Starnes BW; Andersen CA; Ronsivalle JA; Stockmaster NR; Mullenix PS; Statler JD
    J Vasc Surg; 2006 Feb; 43(2):270-6. PubMed ID: 16476600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Femoral endarteritis associated with percutaneous suture closure: new technology, challenging complications.
    Whitton Hollis H; Rehring TF
    J Vasc Surg; 2003 Jul; 38(1):83-7. PubMed ID: 12844094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic and duplex comparison of the perclose and angio-seal percutaneous closure devices.
    Gargiulo NJ; Veith FJ; Ohki T; Scher LA; Berdejo GL; Lipsitz EC; Menegus M; Greenberg M
    Vascular; 2007; 15(1):24-9. PubMed ID: 17382051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First human experience of thermal arterial closure.
    Davidson LJ; Luna J; Virmani R; Asscher JA; Davidson CJ
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):30-6. PubMed ID: 23934606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total percutaneous access for endovascular aortic aneurysm repair ("Preclose" technique).
    Lee WA; Brown MP; Nelson PR; Huber TS
    J Vasc Surg; 2007 Jun; 45(6):1095-101. PubMed ID: 17398056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.